Cleared Traditional

K181624 - Microstream Advance Neonatal-Infant Nas...

K181624 is the FDA 510(k) clearance for Microstream Advance Neonatal-Infant Nas... by Oridion Medical 1987 , Ltd.. It is a Class 2 Anesthesiology device (product code CCK) cleared through the Traditional 510(k) pathway after a 275-day FDA review.

K181624 · Oridion Medical 1987 , Ltd. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2019
Decision
275d
Days
Class 2
Risk

K181624 is an FDA 510(k) clearance for the Microstream Advance Neonatal-Infant Nasal Filter Line with O2 Tubing, Microst.... Classified as Analyzer, Gas, Carbon-dioxide, Gaseous-phase (product code CCK), Class II - Special Controls.

Submitted by Oridion Medical 1987 , Ltd. (Jerusalem, IL). The FDA issued a Cleared decision on March 22, 2019 after a review of 275 days - an extended review cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1400 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Oridion Medical 1987 , Ltd. devices

Submission Details

510(k) Number K181624 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 20, 2018
Decision Date March 22, 2019
Days to Decision 275 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
135d slower than avg
Panel avg: 140d · This submission: 275d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1400
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase

All 123
Devices cleared under the same product code (CCK) and FDA review panel - the closest regulatory comparables to K181624.
Airway Gas Sampling Set, disposable, Adult/Pediatric, TPE, 3m/10ft, Airway Gas Sampling Set, disposable, Adult/Pediatric, TPE, 2m/7ft, Airway Gas Sampling Set, disposable, Infant, TPE, 2m/7ft, Airway Adapter with Luer Connector, Adult/Pediatric
K190824 · Bluepoint Medical GmbH & Co. KG · Dec 2019
MaxCap Ped and MaxCap Neo
K182362 · Maxtec, LLC · May 2019
CARESCAPE Respiratory Modules, E-sCO, E-sCOV, E-sCOVX, E-sCAiO
K183394 · GE Healthcare Finland Oy · May 2019
Microstream Luer Adult-Pediatric Intubated Sampling Line, Microstream Advance Adult-Pediatric Intubated Filter Line
K181467 · Oridion Medical 1987 , Ltd. · Feb 2019
CO2 Sampling Line
K181981 · Tylenol Medical Instruments Co., Ltd. · Feb 2019
MediPines Gas Exchange Monitor (GEM), Accessory Mouthpiece Disposable Assembly
K180902 · Medipines Corporation · Jan 2019